iBio (NASDAQ:IBIO – Get Free Report) and Myriad Genetics (NASDAQ:MYGN – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability. Insider and Institutional Ownership 7.9% of iBio shares […]

ADMA Biologics (NASDAQ:ADMA – Get Free Report) and Myriad Genetics (NASDAQ:MYGN – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Valuation & Earnings This table compares ADMA Biologics […]